2009 July 2; 460(7251): 108–112 | Koichi Araki, Alexandra P. Turner, Virginia Olivia Shaffer, Shivaprakash Gangappa, Susanne A. Keller, Martin F. Bachmann, Christian P. Larsen, and Rafi Ahmed
This study investigates the role of mTOR, the mammalian target of rapamycin, in regulating memory CD8 T cell differentiation. Surprisingly, rapamycin, an mTOR inhibitor, was found to enhance the generation of virus-specific CD8 T cells in mice infected with lymphocytic choriomeningitis virus (LCMV) and in mice vaccinated with a non-replicating VLP-based vaccine. Rapamycin treatment also improved the functional qualities of memory CD8 T cells, as evidenced by increased homeostatic proliferation and better recall responses. The effects of rapamycin were observed during both the expansion and contraction phases of the T cell response, suggesting that it enhances the formation of memory precursors and accelerates the memory differentiation program. Further experiments using RNAi to inhibit mTOR, raptor, or FKBP12 in antigen-specific CD8 T cells confirmed that mTOR acts intrinsically through the mTORC1 pathway to regulate memory T cell differentiation. These findings identify a molecular pathway that regulates memory formation and provide a strategy for improving the functional qualities of vaccine-induced or infection-induced memory T cells.This study investigates the role of mTOR, the mammalian target of rapamycin, in regulating memory CD8 T cell differentiation. Surprisingly, rapamycin, an mTOR inhibitor, was found to enhance the generation of virus-specific CD8 T cells in mice infected with lymphocytic choriomeningitis virus (LCMV) and in mice vaccinated with a non-replicating VLP-based vaccine. Rapamycin treatment also improved the functional qualities of memory CD8 T cells, as evidenced by increased homeostatic proliferation and better recall responses. The effects of rapamycin were observed during both the expansion and contraction phases of the T cell response, suggesting that it enhances the formation of memory precursors and accelerates the memory differentiation program. Further experiments using RNAi to inhibit mTOR, raptor, or FKBP12 in antigen-specific CD8 T cells confirmed that mTOR acts intrinsically through the mTORC1 pathway to regulate memory T cell differentiation. These findings identify a molecular pathway that regulates memory formation and provide a strategy for improving the functional qualities of vaccine-induced or infection-induced memory T cells.